• Abdominal Muscle Deficiency Syndrome • Branchio-Oto-Renal syndrome • Cerebral Gigantism • Cerebral Palsy • Chronic Granulomatous Disease • Duchenne Muscular Dystrophy • Eagle-Barrett Syndrome • Fetal Alcohol Syndrome (1) (2) • Fibrodysplasia Ossificans Progressiva • Fragile X Syndrome (1) (2) (3) • Hunter Syndrome • Iliac Horn Syndrome • Juvenile Hemochromatosis • Klippel-Trenaunay Syndrome • LEOPARD Syndrome • Mowat-Wilson Syndrome • Onycho-Osteodysplasia • Organic Acidemia • Prune Belly Syndrome • Russel Silver Syndrome • Sotos Syndrome • Triad Syndrome • Trisomy 13 • Turner-Keiser Syndrome • Williams Syndrome
• Abdominal Muscle Deficiency Syndrome
• Branchio-Oto-Renal syndrome
• Cerebral Gigantism
• Cerebral Palsy
• Chronic Granulomatous Disease
• Duchenne Muscular Dystrophy
• Eagle-Barrett Syndrome
• Fetal Alcohol Syndrome (1)(2)
• Fibrodysplasia Ossificans Progressiva
• Fragile X Syndrome(1)(2)(3)
• Hunter Syndrome
• Iliac Horn Syndrome
• Juvenile Hemochromatosis
• Klippel-Trenaunay Syndrome
• LEOPARD Syndrome
• Mowat-Wilson Syndrome
• Onycho-Osteodysplasia
• Organic Acidemia
• Prune Belly Syndrome
• Russel Silver Syndrome
• Sotos Syndrome
• Triad Syndrome
• Trisomy 13
• Turner-Keiser Syndrome
• Williams Syndrome
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Andrew Alexis, MD, MPH, highlights positive lebrikizumab-lbkz data for atopic dermatitis
June 25th 2025Lebrikizumab demonstrated efficacy and safety in patients with skin of color and moderate-to-severe atopic dermatitis in the ADmirable trial. Trial investigator Andrew Alexis, MD, MPH, reacts.